Comments

Gilead Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GILDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$108.00

At close: Jun 17 EDT

$108.00

0.000.00%

Pre-Market: 6:55 PM EDT

The dividend Ex-Date was 5 days ago

Gilead Sciences (GILD) Forecast

News Earnings Gilead Sciences (GILD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Gilead Sciences Stock Price, Quotes and Forecasts | NASDAQ:GILD | Benzinga

Explore Gilead Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GILD.

Open	-
Close	-
Volume / Avg.	0 / 9.23M
Day Range	- - -
52 Wk Range	62.69 - 119.96
Market Cap	$134.34B
P/E Ratio	22.69
Dividend Yield	2.93%
Exchange	NASDAQ
RSI	44
Short Interest	1.68%
Days to Cover	2.75

Recent News

Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising concerns over global access and equity.

Vandana Singh

Gilead's HIV Pipeline Gains Traction With Upcoming FDA Decision For HIV-1 Drug

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S. PrEP users by 2035.

Vandana Singh

Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation

US-China agree to slash tariffs by over 100%, easing fears of economic slowdown and inflation. Markets cheer with futures rising and yields up.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 9.23M
Day Range	- - -
52 Wk Range	62.69 - 119.96
Market Cap	$134.34B
P/E Ratio	22.69
Dividend Yield	2.93%
Exchange	NASDAQ
RSI	44
Short Interest	1.68%
Days to Cover	2.75

About Gilead Sciences, Inc.

Sector

Health Care

Industry

Biotechnology

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with t...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Gilead Sciences (GILD) stock?

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Who are Gilead Sciences (GILD) competitors?

Other companies in Gilead Sciences’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

Gilead Sciences has a consensus price target of $106.59.

What is the current price for Gilead Sciences (GILD)?

The stock price for Gilead Sciences (NASDAQ: GILD) is $108 last updated June 17, 2025 at 6:55 PM EDT.

Does Gilead Sciences (GILD) pay a dividend?

A quarterly cash dividend of 0.79 per share of Class A Common Stock. The quarterly cash dividend was payable on June 27, 2025 to stockholders of record on June 13, 2025.

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

Gilead Sciences’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Gilead Sciences (GILD) going to split?

There is no upcoming split for Gilead Sciences.

What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.